Researching AMD

March 13, 2019

Drug Delivery Device for Age-Related Macular Degeneration (AMD)
Karl G. Csaky, M.D., Ph.D., Director, Molecular Ophthalmology Laboratory, is working with his research team to develop a drug delivery device for patients with age-related macular degeneration (AMD). It is a small Polymer device that slowly releases therapeutic drugs as needed over a period of weeks, months or years as prescribed by your physician. The device is placed on the outer part of the eye and does not interfere with patient vision or comfort. The device can remain in place for a long period of time as prescribed by the physician care team. Placement of the implant on the surface of the eye, rather than inside the eye, allows for long-term drug delivery to the eye. This innovative drug delivery device allows physicians to administer medication delivery in a less invasive way, and better manage the disease.

Researching AMD

Related Articles

Fogg Charitable Trust Awards $50,000 Grant to the Retina Foundation Retina Foundation Presents New Data & Conclusions at ARVO 2018 Choroideremia Research Is Necessary to Help Prevent Blindness at an Early Age Investigating the Impact of Lazy Eye on Reading Speed and Motor Skills in Children – Video Update New Technology Gives ‘Second Sight’ to the Blind
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • Please check all that apply:
  • This field is for validation purposes and should be left unchanged.
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form